Vivus’s diet pill faces generic threat from Actavis

[Reuters] – Vivus Inc said on Friday drugmaker Actavis Plc plans to market a generic version of Vivus’s obesity drug Qsymia that was approved in July 2012. Actavis had filed a U.S. marketing application for its generic version of the diet pill, according more

View todays social media effects on ACT

View the latest stocks trending across Twitter. Click to view dashboard

See who Actavis is hiring next, click here to view